Shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eight research firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $145.25.
A number of brokerages have recently commented on SLAB. Needham & Company LLC reaffirmed a "buy" rating and issued a $150.00 target price on shares of Silicon Laboratories in a report on Wednesday, May 14th. KeyCorp upped their price target on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a report on Tuesday, July 8th. Susquehanna upped their price objective on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a research note on Tuesday, July 22nd. Stifel Nicolaus boosted their target price on Silicon Laboratories from $144.00 to $160.00 and gave the stock a "buy" rating in a report on Friday, July 18th. Finally, Benchmark reaffirmed a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a research report on Tuesday, May 27th.
Get Our Latest Analysis on SLAB
Silicon Laboratories Stock Performance
Shares of NASDAQ:SLAB traded down $6.79 during trading on Monday, hitting $126.76. The company's stock had a trading volume of 1,071,023 shares, compared to its average volume of 437,144. Silicon Laboratories has a fifty-two week low of $82.82 and a fifty-two week high of $160.00. The company has a market capitalization of $4.13 billion, a PE ratio of -24.81 and a beta of 1.48. The business has a 50 day moving average price of $138.54 and a two-hundred day moving average price of $128.30.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.02. The company had revenue of $192.85 million for the quarter, compared to analyst estimates of $192.57 million. Silicon Laboratories had a negative return on equity of 8.80% and a negative net margin of 25.16%. The business's quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the company posted ($0.56) earnings per share. As a group, equities analysts expect that Silicon Laboratories will post -0.97 earnings per share for the current fiscal year.
Insider Transactions at Silicon Laboratories
In other Silicon Laboratories news, SVP Robert J. Conrad sold 4,029 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $131.20, for a total transaction of $528,604.80. Following the transaction, the senior vice president owned 25,380 shares of the company's stock, valued at approximately $3,329,856. This trade represents a 13.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Robert Matthew Johnson sold 5,879 shares of the company's stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $131.20, for a total transaction of $771,324.80. Following the completion of the sale, the chief executive officer directly owned 73,688 shares of the company's stock, valued at $9,667,865.60. The trade was a 7.39% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,080 shares of company stock worth $1,452,290. Corporate insiders own 1.60% of the company's stock.
Hedge Funds Weigh In On Silicon Laboratories
A number of institutional investors have recently modified their holdings of SLAB. Capital Research Global Investors lifted its position in Silicon Laboratories by 23.3% during the 4th quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company's stock worth $264,827,000 after buying an additional 403,010 shares in the last quarter. Westfield Capital Management Co. LP acquired a new position in Silicon Laboratories during the 1st quarter worth about $37,249,000. Nuveen LLC acquired a new position in Silicon Laboratories during the 1st quarter worth about $32,338,000. Adage Capital Partners GP L.L.C. lifted its position in Silicon Laboratories by 116.7% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 525,022 shares of the semiconductor company's stock worth $59,102,000 after buying an additional 282,785 shares in the last quarter. Finally, Norges Bank bought a new stake in Silicon Laboratories during the 4th quarter worth about $34,622,000.
About Silicon Laboratories
(
Get Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Recommended Stories

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report